Bevacizumab-800CW
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Bevacizumab-800CW, covering 2026-03-30 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas [Phase 2]